MRNA Nov 2024 90.000 call
| Previous close | 0.4000 |
| Open | 0.5700 |
| Bid | 0.4000 |
| Ask | 0.4800 |
| Strike | 90.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.4000 - 0.5700 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.81k |
Yahoo FinanceLow RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst said, and could mean weak earnings for manufacturers.
Insider MonkeyJim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other Jim Cramer stocks that finished dead last. In a recent episode of Mad Money, Jim Cramer examined market trends of the […]
PR NewswireInvaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the appointment of André Andonian as the new Chairman of its Board of Directors. Robert Berendes has decided to step down after serving as Chairman of the Board since 2019 and will continue to serve on the board of Invaio.
